What is Emtricitabine (FTC)?

Category: Prescription Drugs

Most popular types: Emtriva Coviracil

false

See also: Truvada

Emtricitabine is a nucleoside reverse transcriptase inhibitor used in the treatment of HIV infection in combination with at least two other antiretroviral agents. It may also be used for Hepatitis B (with HIV coinfection).

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 0
Moderate 0
Mild 1
None 1

Commonly reported side effects and conditions associated with Emtricitabine (FTC)

Side effect Patients Percentage

Why patients stopped taking Emtricitabine (FTC)

Multiple reasons could be selected

Reason Patients Percentage
Course of treatment ended 1
See all 2 patients who've stopped taking Emtricitabine (FTC)

Duration

Stopped taking Emtricitabine (FTC)

Duration Patients Percentage
Less than 1 month 1
6 months - 1 year 1
Adherence
Adherence Evaluations Percentage
Always 1
Usually 1
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations Percentage
Very hard to take 0
Somewhat hard to take 0
A little hard to take 0
Not at all hard to take 2
Cost per month
Cost per month Evaluations Percentage
$200+ 0
$100-199 0
$50-99 0
$25-49 1
< $25 1
Not specified 0

What people switch to and from

Patients started taking Emtricitabine (FTC) after stopping:

Treatment Patients Percentage
Abacavir-lamivudine (ABC/3TC) (Epzicom) 1
Efavirenz-Emtricitabine-Tenofovir disoproxil fumarate (Atripla) 1
Last updated:
There are no evaluations for Emtricitabine (FTC).